No Data
No Data
T2 Biosystems Reinforces Market Position With Extended Vizient Agreement
Express News | T2 Biosystems Extends Multi-Year Capital Equipment Supplier Agreement With Vizient; Vizient Members Continue Access To Broader Exposure And Contracted Pricing For T2Dx Instrument, T2Bacteria Panel And T2Candida Panel
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement With Vizient, Inc.
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced t
T2 Biosystems Anticipates Breakthroughs and Extends NASDAQ Compliance
T2 Biosystems Targets Commercial Launch Of T2Lyme Panel In Q3 - Quick Facts
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
Anticipates commercial launch of the T2Lyme Panel in the third quarter of 2024LEXINGTON, Mass., March 20, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the
No Data